MP53-14 MULTIMODAL TREATMENT FOR HIGH-RISK PROSTATE CANCER WITH HIGH-DOSE INTENSITY-MODULATED RADIATION THERAPY, CONCURRENT INTENSIFIED-DOSE DOCETAXEL AND LONG-TERM ANDROGEN DEPRIVATION THERAPY AFTER RADICAL PROSTATECTOMY AND LYMPHADENECTOMY: RESULTS OF A PROSPECTIVE PHASE II TRIAL.
2012 ◽
Vol 110
(11b)
◽
pp. E721-E726
◽
2014 ◽
Vol 90
(1)
◽
pp. S418-S419
2013 ◽
Vol 85
(3)
◽
pp. 686-692
◽
2014 ◽
Vol 88
(2)
◽
pp. 339-344
◽
2008 ◽
Vol 72
(1)
◽
pp. S74-S75
◽
2019 ◽
Vol 24
(10)
◽
pp. 1247-1255
◽
2006 ◽
Vol 176
(4)
◽
pp. 1415-1419
◽